UK Markets closed

NVO Mar 2023 120.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
5.78+3.18 (+122.31%)
As of 08:36AM EST. Market open.
Full screen
Previous close2.60
Open6.48
Bid4.50
Ask6.80
Strike120.00
Expiry date2023-03-17
Day's range5.78 - 6.48
Contract rangeN/A
Volume2
Open interest3
  • Reuters

    Drugmakers prevail in dispute over U.S. discount drug program

    (Reuters) -Drug manufacturers can limit healthcare providers' use of outside pharmacies for dispensing drugs under a federal drug discount program, a federal appeals court ruled Monday. The ruling from a three-judge panel of the 3rd U.S. Circuit Court of Appeals based in Philadelphia is a victory for Sanofi SA, Novo Nordisk AS and AstraZeneca PLc. The companies had sued the U.S. Department of Health and Human Services (HHS) after it ordered them to stop restricting sales of discounted drugs to so-called contract pharmacies.

  • Zacks

    Eli Lilly (LLY) Lymphoma Candidate Pirtobrutinib Gets FDA Nod

    The FDA approves Eli Lilly's Jaypirca (pirtobrutinib) under an accelerated approval pathway as a treatment for mantle cell lymphoma (MCL).

  • Zacks

    Merck (MRK) to Report Q4 Earnings: What's in the Cards?

    Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda when the company reports Q4 earnings.